IN2013CH01325AIN1325CH2013AIN2013CH01325AIN 2013CH01325 AIN2013CH01325 AIN 2013CH01325AIN 1325CH2013 AIN1325CH2013 AIN 1325CH2013AIN 2013CH01325 AIN2013CH01325 AIN 2013CH01325A
Authority
IN
India
Prior art keywords
repeating unit
polymer compound
mpa1
water
mass
Prior art date
Application number
Inventor
Norihide Shimohara
Ryoichi Nakano
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2012075177Aexternal-prioritypatent/JP2013204939A/en
Priority claimed from JP2012075120Aexternal-prioritypatent/JP5579769B2/en
Priority claimed from JP2012075119Aexternal-prioritypatent/JP5579768B2/en
Priority claimed from JP2013030384Aexternal-prioritypatent/JP5579887B2/en
Application filed by Fujifilm CorpfiledCriticalFujifilm Corp
Publication of IN2013CH01325ApublicationCriticalpatent/IN2013CH01325A/en
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications
(AREA)
Abstract
An ink composition of the present invention includes, (a) a polymer compound which includes a repeating unit (a-1) having a partial structure expressed by the following General Formula (1), a repeating unit (a-2) which has a hydrophilic group and accounts for 8% to 25% by mass with respect to the total mass of the polymer compound, and a repeating unit (a-3) having a hydrophobic group, the polymer compound having a solubility parameter in an unneutralized state of 20.7 MPa1'2 to 23.0 MPa1/2; (b) water; and (c) a water-soluble organic solvent.
Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy